Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00258_DB00759> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00258_DB00759 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00258_DB00759 label "DDI between Calcium Acetate and Tetracycline - Calcium salts such as calcium acetate may decrease the serum concentration of tetracycline derivatives such as tetracycline. In general, the coadministration of oral calcium salts and oral tetracycline derivatives should be avoided. Interactions may be able to be minimized by administering oral calcium preparations several hours before or after the dose of the oral tetracycline derivatives. Even with dose separation, therapy may still be compromised. Monitor for decreased therapeutic effect of oral tetracycline derivatives. [drugbank_resource:DB00258_DB00759]" assertion.
- drugbank_resource:DB00258_DB00759 identifier "drugbank_resource:DB00258_DB00759" assertion.
- drugbank_resource:DB00258_DB00759 title "DDI between Calcium Acetate and Tetracycline - Calcium salts such as calcium acetate may decrease the serum concentration of tetracycline derivatives such as tetracycline. In general, the coadministration of oral calcium salts and oral tetracycline derivatives should be avoided. Interactions may be able to be minimized by administering oral calcium preparations several hours before or after the dose of the oral tetracycline derivatives. Even with dose separation, therapy may still be compromised. Monitor for decreased therapeutic effect of oral tetracycline derivatives." assertion.